InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Schroeder Blake. Director active across 1 company, notably AXIM BIOTECHNOLOGIES, INC.. Aggregated, 1 disclosures have been logged. Activity tracked since 22 August 2022. The latest transaction was disclosed on 22 August 2022 (C). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration